Ongoing, global campaign demanding universal, equitable access to HCV cure for everyone who needs it.
Stigma, discrimination, exclusion, and criminalization of people living with HCV continue to be one of the biggest barriers for getting more people cured and linked to care. More
A policy brief, developed by TAG, presents online survey data from 23 countries on some of the key HCV diagnostics and policy barriers that inhibit access to HCV care in LMICs. More
An article in 2023 issue of TAGline explores how to reimagine HCV elimination strategies now that intellectual property is no longer restricting access to generic cures. More